Breakthrough Alliance Europe Returns to Paris – Global Investors, Health System Leaders, and Scaling Startups Convene at Hôtel-Dieu

Digital health is entering a new reality: capital is selective, adoption asymmetric, and only solutions backed by real evidence are breaking through. In response, HITLAB today announced the return of Breakthrough Alliance (BTA) Europe, a high-impact gathering designed to help healthcare innovation move from promising pilots to scalable, investment-ready businesses.

Taking place March 31–April 2, 2026, at the historic Hôtel-Dieu de Paris, the second annual event will convene venture investors, pharmaceutical and health system executives, policymakers, and carefully selected startups focused on one outcome: turning validated innovation into market adoption.

Unlike traditional conferences, Breakthrough Alliance Europe is structured as an execution environment—connecting companies ready to scale with the capital, partnerships, and regulatory insight required to succeed in Europe’s complex healthcare markets while strengthening transatlantic expansion pathways.

“The digital health market has shifted from funding innovation to funding proof,” said Laurent van Lerberghe, Chairman of HITLAB’s BTA Europe and CEO of Ballas Invest. “Breakthrough Alliance Europe brings together the people who can translate evidence into adoption, investment, and real healthcare impact.”

Why This Moment Matters

Across global healthcare markets, investors and buyers are asking harder questions:

  • Does the solution demonstrate measurable outcomes?
  • Can it survive reimbursement scrutiny?
  • Is there credible evidence supporting scale?

BTA Europe is built to answer those questions directly—placing founders, investors, and healthcare decision-makers into structured conversations focused on commercialization, validation, and growth.

What Participants Gain

  • Direct Investor and Strategic Access -Engage venture funds, corporate innovation leaders, and healthcare executives actively deploying capital and partnerships.
  • Evidence-to-Adoption Strategy Sessions – Deep discussions on reimbursement, regulatory navigation, health economics, and AI validation requirements.
  • Curated Innovation Showcases -High-growth startups presenting solutions positioned for European and global expansion.
  • Executive Matchmaking -Structured networking connecting innovators with investors, accelerators, and commercialization partners.

Late Breaker Evidence Call Now Open

HITLAB is inviting late-breaker posters and speakers presenting new research, validation studies, and real-world outcomes demonstrating measurable healthcare value.

Priority submissions include:

  • Clinical validation and outcomes evidence
  • Health economics and reimbursement strategy
  • Responsible AI deployment and testing
  • Cross-border regulatory and evidence alignment

Late Breaker Evidence Call Now Open

Participants include leaders shaping the future of healthcare innovation:

  • Nicolas Castoldi — Executive Director, Hôtel-Dieu
  • Laurent van Lerberghe — CEO, Ballas Invest; Chair, HITLAB BTA Europe
  • Bill Taranto — President, Merck Global Health Innovation Fund
  • Chrysanthi Dori — VP Clinical Informatics Services, Medidata
  • Johanna Michielin — Regional Director Europe, BioLabs
  • Vlad Neste — Director Life Sciences & Healthcare, Nagarro

Full speaker lineup here.

A Gateway Between European and U.S. Innovation Markets

By convening validated startups alongside investors and healthcare institutions seeking deployable solutions, Breakthrough Alliance Europe aims to accelerate adoption of proven digital health technologies while strengthening collaboration between European and U.S. ecosystems.

Registration and poster submissions are now open. HITLAB has secured preferred accommodations at Cheval Blanc Paris exclusively for attendees.

About HITLAB

By convening validated startups alongside investors and healthcare institutions seeking deployable solutions, Breakthrough Alliance Europe aims to accelerate adoption of proven digital health technologies while strengthening collaboration between European and U.S. ecosystems.

Registration and poster submissions are now open. HITLAB has secured preferred accommodations at Cheval Blanc Paris exclusively for attendees.

Explore Recent Posts